Influenzinum (2024-2025)

FDA Drug Profile — Influenzinum 200C

Influenzinum (2024-2025) is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Influenzinum 200C. Available dosage form: liquid.

Drug details

Generic Name
Influenzinum (2024-2025)
Brand Names
Influenzinum 200C
Sponsor
Energique, Inc.
NDC Codes
1
Dosage Forms
LIQUID
Routes
ORAL
Active Ingredients
INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE, INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE

Indications and Usage

USES: May temporarily relieve symptoms associated with the flu: •aches •pains.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Warnings

WARNINGS: Stop use and ask a doctor if symptoms persist for more than 3 days. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. DO NOT USE IF TAMPER EVIDENT SEAL IS BROKEN OR MISSING. Store in a cool, dry place.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.